Burlington, MA, United States of America

Kris Wang

This inventor holds 1 USPTO granted patent. Top assignee: Flexion Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kris Wang. Retrieved from https://idiyas.com/inventor/kris-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Kris Wang

Introduction

Kris Wang is an accomplished inventor based in Burlington, MA (US). He has made significant contributions to the field of biological delivery systems, particularly in the treatment of osteoarthritis. His innovative work has led to the development of a patented technology that holds promise for improving patient outcomes.

Latest Patents

Kris Wang holds a patent titled "Effective Dosages of an Adenoviral-Based Biological Delivery and Expression System for Use in the Treatment of Osteoarthritis in Humans, and Compositions Comprising the Same." This patent represents a significant advancement in the use of adenoviral vectors for therapeutic applications, specifically targeting osteoarthritis.

Career Highlights

Kris Wang is currently employed at Flexion Therapeutics, Inc., where he continues to work on innovative solutions in the field of therapeutics. His expertise in biological delivery systems has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Kris collaborates with talented professionals such as Scott Kelley and Rebecca Senter, contributing to a dynamic team focused on advancing medical technologies.

Conclusion

Kris Wang's contributions to the field of biological delivery systems exemplify the impact of innovation in medicine. His work not only enhances our understanding of therapeutic applications but also paves the way for future advancements in treating osteoarthritis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…